Uroplasty, Inc. (UPI):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Uroplasty, Inc. (UPI) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME2330FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Uroplasty, Inc. (Uroplasty) is a medical device company. The company develops, manufactures and markets products for the minimally invasive treatment of voiding dysfunctions and pelvic disorders. Its healthcare professional products include urgent PC neuromodulation system, macroplastique implants, macroplastique implantation system, and PTQ implants. Uroplasty also offers urinary incontinence, faecal incontinence, vesicoureteral reflux and vocal cord paralysis. The company’s PC neuromodulation system is used to treat overactive bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Uroplasty is headquartered in Minnetonka, Minnesota, the US.

Uroplasty, Inc. Key Recent Developments

Dec 23, 2013: Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve Stimulation By Medical Mutual
Dec 10, 2013: Uroplasty Names David B. Perry Vice President Of Marketing
Nov 21, 2013: Uroplasty to participate in the Piper Jaffray Healthcare Conference
Oct 24, 2013: Uroplasty Sets New Quarterly Revenue Record During Fiscal Second Quarter 2014
Oct 10, 2013: Uroplasty To Announce Second Quarter Fiscal 2014 Financial Results On October 24, 2013

This comprehensive SWOT profile of Uroplasty, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Uroplasty, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Uroplasty, Inc. – Key Information
Uroplasty, Inc. – Overview
Uroplasty, Inc. – Key Employees
Uroplasty, Inc. – Key Employee Biographies
Uroplasty, Inc. – Key Operational Heads
Uroplasty, Inc. – Major Products and Services
Uroplasty, Inc. – History
Uroplasty, Inc. – Company Statement
Uroplasty, Inc. – Locations And Subsidiaries
Uroplasty, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Uroplasty, Inc. – Business Description
Uroplasty, Inc. – Corporate Strategy
Uroplasty, Inc. – SWOT Analysis
SWOT Analysis – Overview
Uroplasty, Inc. – Strengths
Uroplasty, Inc. – Weaknesses
Uroplasty, Inc. – Opportunities
Uroplasty, Inc. – Threats
Uroplasty, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Uroplasty, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Uroplasty, Inc., Key Information
Uroplasty, Inc., Key Ratios
Uroplasty, Inc., Share Data
Uroplasty, Inc., Major Products and Services
Uroplasty, Inc., History
Uroplasty, Inc., Key Employees
Uroplasty, Inc., Key Employee Biographies
Uroplasty, Inc., Key Operational Heads
Uroplasty, Inc., Other Locations
Uroplasty, Inc., Subsidiaries
Uroplasty, Inc., Key Manufacturing facilities
Uroplasty, Inc., Key Competitors
Uroplasty, Inc., SWOT Analysis
Uroplasty, Inc., Ratios based on current share price
Uroplasty, Inc., Annual Ratios
Uroplasty, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Uroplasty, Inc., Performance Chart
Uroplasty, Inc., Ratio Charts

★海外企業調査レポート[Uroplasty, Inc. (UPI):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JDS Uniphase Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' JDS Uniphase Corporation Merger …
  • Perennial International Limited (725):企業概要、財務及び戦略的SWOT分析
    Summary Perennial International Limited (Perennial) is an electrical equipment manufacturing company. The company designs, manufactures, and trades cables and wire products. It offers products such as plastic resins, low voltage cables, tooling and molding, wire harnesses, and power cords. Perennial …
  • Plastopil Hazorea Company Ltd:企業の戦略・SWOT・財務分析
    Plastopil Hazorea Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Plastopil Hazorea Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Newcrest Mining Limited:企業の戦略・SWOT・財務分析
    SummaryNewcrest Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • VWR International, LLC:企業のM&A・提携・投資分析
    VWR International, LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's VWR International, LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • ArcelorMittal:企業のM&A・提携・投資分析
    ArcelorMittal - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ArcelorMittal Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • ViroMed Co., Ltd. (084990):企業の財務及び戦略的SWOT分析
    Summary ViroMed Co., Ltd. (ViroMed), formerly ViroMedica Pacifica is a biotechnology company that develops and manufactures biopharmaceuticals and reagents. The company’s bioparmaceutical products include VM501, VM202-PAD, VM202-DPN, VM202-ALS and VM206. It offers nutraceutical products such as alle …
  • Menicon Co., Ltd. (7780):企業財務及び戦略的SWOT分析
    Summary Menicon Co., Ltd. (Menicon) is a medical device company that manufactures and markets ophthalmic products. The company’s products include soft contact lens, hard contact lens, astigmatic contact lens and bifocal contact lenses. It offers contact lens care products such as epica cold, epica c …
  • Axcelis Technologies, Inc. (ACLS):企業財務及び戦略的SWOT分析
    Summary Axcelis Technologies, Inc. (Axcelis) is a technology and communication company that offers industrial equipment. The company design and manufactures products for semiconductor industries. It offers products such as ion implantation. The company’s ion implantation product include high current …
  • TransAtlantic Petroleum, Ltd. (formerly TransAtlantic Petroleum Corp.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TransAtlantic Petroleum, Ltd. ( …
  • Sanofi (SAN)-製薬・医療分野:企業M&A・提携分析
    Summary Sanofi is a healthcare company, which focuses on the research, development, manufacture and marketing a wide range of medicines and vaccines. Its product portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; human v …
  • United Cooperative Assurance Co :企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "United Cooperative Assurance Co " The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric s …
  • Pathogenica Inc-医療機器分野:企業M&A・提携分析
    Summary Pathogenica Inc (Pathogenica) is a medical device company that offers multiplex bacterial detection and genotyping kit. The company provides medical diagnostic sequencing products and services for research and clinical use. Its scientific consulting services offers experimental design, DxSeq …
  • Woolworths Ltd (WOW):企業の財務・戦略的SWOT分析
    Woolworths Ltd (WOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Moorim Paper Co., Ltd.:企業の戦略・SWOT・財務分析
    SummaryMoorim Paper Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Repower AG (REPI):企業の財務及び戦略的SWOT分析
    Summary Repower AG (Repower) is an energy company that produces, transmits and distributes electricity. The company was formerly known as Ratia Energie AG. It generates electric energy from hydropower, combined-cycle gas power plant and wind power plants. Repower’s projects include Lagobianco pumped …
  • Virgin Active Limited:企業概要およびSWOT分析
    Summary Canadean's "Virgin Active Limited: Travel and Tourism - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, compan …
  • Salesforce.com, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Salesforce.com, Inc. Mergers an …
  • High Throughput Genomics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' High Throughput Genomics, Inc. …
  • Celgene Corporation:製品開発パイプライン動向2015
    Celgene Corporation - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Celgene Corporation - Product Pipeline Review - 2015’, provides an overview of the Celgene Corporation’s pharmaceutical research and development focus. This report provides comprehensive information on the current …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆